Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-13 5:55 pm Purchase | 2022-12-31 | 13G | REPARE THERAPEUTICS INC RPTX | BIOTECHNOLOGY VALUE FUND L P | 8,291,988 19.800% | 150,000 (+1.84%) | Filing History |
| 2023-02-13 5:53 pm Purchase | 2022-12-31 | 13G | AC IMMUNE SA SHS ACIU | BIOTECHNOLOGY VALUE FUND L P | 7,428,379 8.900% | 366,000 (+5.18%) | Filing History |
| 2023-02-13 5:53 pm Purchase | 2022-12-31 | 13G | VIRACTA THERAPEUTICS INC VIRX | BIOTECHNOLOGY VALUE FUND L P | 3,833,785 9.980% | 102,041 (+2.73%) | Filing History |
| 2023-02-13 5:51 pm Sale | 2022-12-31 | 13G | X4 PHARMACEUTICALS INC XFOR | BIOTECHNOLOGY VALUE FUND L P | 75,280 1.900% | -25,642 (-25.41%) | Filing History |
| 2023-02-13 5:28 pm Purchase | 2023-02-03 | 13G | STRUCTURE THERAPEUTICS INC SPO GPCR | BIOTECHNOLOGY VALUE FUND L P | 12,660,518 11.100% | 12,660,518 (New Position) | Filing History |
| 2023-02-06 4:43 pm Purchase | 2023-01-25 | 13G | JASPER THERAPEUTICS INC JSPR | BIOTECHNOLOGY VALUE FUND L P | 990,000 9.100% | 990,000 (New Position) | Filing History |
| 2023-01-03 5:01 pm Purchase | 2022-12-22 | 13G | ZYMEWORKS INC ZYME | BIOTECHNOLOGY VALUE FUND L P | 5,870,000 9.300% | 5,870,000 (New Position) | Filing History |
| 2022-12-23 5:08 pm Sale | 2022-12-21 | 13G | PHAXIAM THERAPEUTICS S.A. AMER PHXM | BIOTECHNOLOGY VALUE FUND L P | 229,930 7.400% | -281,988 (-55.08%) | Filing History |
| 2022-12-21 4:40 pm Purchase | 2022-12-19 | 13G | THIRD HARMONIC BIO INC THRD | BIOTECHNOLOGY VALUE FUND L P | 4,365,933 10.800% | 864,119 (+24.68%) | Filing History |
| 2022-12-16 4:45 pm Purchase | 2022-12-06 | 13G | NLS PHARMACEUTICS LTD COM SHS NLSP | BIOTECHNOLOGY VALUE FUND L P | 17,148 19.990% | 17,148 (New Position) | Filing History |
| 2022-12-05 4:45 pm Purchase | 2022-11-23 | 13G | KURA ONCOLOGY INC KURA | BIOTECHNOLOGY VALUE FUND L P | 3,547,083 5.300% | 2,301,171 (+184.70%) | Filing History |
| 2022-11-10 4:51 pm Unchanged | 2022-11-08 | 13D | RAIN ONCOLOGY INC. RAIN | BIOTECHNOLOGY VALUE FUND L P | 3,526,729 14.200% | 0 (Unchanged) | Filing History |
| 2022-11-07 4:50 pm Purchase | 2022-10-27 | 13G | VERSARTIS INC ARAV | BIOTECHNOLOGY VALUE FUND L P | 6,109,058 9.990% | 6,109,058 (New Position) | Filing History |
| 2022-09-29 4:28 pm Purchase | 2022-09-19 | 13G | ALLAKOS INC ALLK | BIOTECHNOLOGY VALUE FUND L P | 5,006,921 5.900% | 5,006,921 (New Position) | Filing History |
| 2022-09-26 4:57 pm Purchase | 2022-09-15 | 13G | THIRD HARMONIC BIO INC THRD | BIOTECHNOLOGY VALUE FUND L P | 3,501,814 9.100% | 3,501,814 (New Position) | Filing History |
| 2022-09-26 4:54 pm Purchase | 2022-09-14 | 13G | POINT BIOPHARMA GLOBAL INC PNT | BIOTECHNOLOGY VALUE FUND L P | 5,590,048 5.400% | 2,669,522 (+91.41%) | Filing History |
| 2022-08-26 5:11 pm Purchase | 2022-08-16 | 13G | VIGIL NEUROSCIENCE INC VIGL | BIOTECHNOLOGY VALUE FUND L P | 2,739,727 7.500% | 2,739,727 (New Position) | Filing History |
| 2022-08-23 4:45 pm Purchase | 2022-08-22 | 13D | KYMERA THERAPEUTICS INC KYMR | BIOTECHNOLOGY VALUE FUND L P | 4,692,604 8.600% | 553,846 (+13.38%) | Filing History |
| 2022-08-11 4:48 pm Purchase | 2022-08-09 | 13D | CTI BIOPHARMA CORP CTIC | BIOTECHNOLOGY VALUE FUND L P | 28,463,021 19.990% | 11,339,998 (+66.23%) | Filing History |
| 2022-07-29 4:37 pm Purchase | 2022-07-27 | 13G | CYTOMX THERAPEUTICS INC CTMX | BIOTECHNOLOGY VALUE FUND L P | 6,595,801 10.100% | 792,101 (+13.65%) | Filing History |